Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CELLEBRATE AMDC-USR versus placebo in women with stress urinary incontinence
2017-000956-25Phase 3Unknown
- Sponsor
- Cook MyoSite
- Start
- May 2018
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in stress urinary incontinence (SUI) comparing AMDC-USR with Placebo (2 arms). Primary endpoint: Responder rate at 12 months. Status: unknown.
02
Drugs
AMDC-USR
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on 2017-000956-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000956-25.